<DOC>
	<DOCNO>NCT01913002</DOCNO>
	<brief_summary>This Phase 1 study investigate effect higher dos LX4211 ( 800 mg 2000 mg ) differ placebo mean change QTcI Baseline healthy subject .</brief_summary>
	<brief_title>Study Define Electrocardiogram Effects Single Dose LX4211 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Adult subject ≥18 ≤55 year age Vital sign Screening follow range : systolic blood pressure , 90140 mmHg ; diastolic blood pressure , 5090 mmHg ; heart rate , 45100 bpm Body mass index ( BMI ) ≥18 ≤35 kg/sq Able willing provide write informed consent Nonsmoker use tobacco product least 3 month prior Screening Willing adhere prohibition restriction specify protocol Able tolerate prolong period quiet , motionless , supervise rest Use medication ( prescription , overthecounter , herbal tea , supplement ) within 5 day dose Use investigational agent study treatment within 30 day prior Screening Use protein antibodybased therapeutic agent within 3 month prior Screening Prior exposure LX4211 Daily use cigarettes tobacco product within 3 month prior Screening participate study History major surgery within 6 month prior Screening History serious adverse reaction hypersensitivity inactive component LX4211 History renal disease significantly abnormal kidney function test History hepatic disease significantly abnormal liver function test Women breastfeed plan become pregnant study History active infection within 14 day prior Screening History alcohol substance abuse within 2 year prior Screening History hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody ( HCV Ab ) , HIV1 HIV2 Presence clinically significant physical , laboratory , ECG finding ( eg , QTcF &gt; 450 msec female QTcF &gt; 430 msec male ) Screening &gt; 30 premature ventricular beat per hour telemetry ECG monitoring Day 2 Period 1 History additional risk factor presence family history Short QT Syndrome , Long QT Syndrome , sudden unexplained death young age ( &lt; =40 year ) , drown sudden infant death syndrome first degree relative ( ie , biological parent , sibling , child ) Any skin condition likely interfere ECG electrode placement adhesion Any skin condition likely interfere ECG electrode placement adhesion Donation loss &gt; 400 mL blood blood product within 3 month prior Screening Positive urine glucose Screening Positive pregnancy test Screening Positive urine screen drug abuse Screening Positive urine test alcohol Screening Inability difficulty swallow whole tablet capsule Unable unwilling communicate cooperate Investigator reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>